French biotechnology company MedDay on Friday announced encouraging results for a multiple sclerosis (MS) drug trial, saying it decreased its progress and in some cases led to a "significant improvement" ...
13 hours ago
Acute myeloid leukemia is a conundrum among cancers. Immature cells swamp the bone marrow, crowd out healthy cells, and all too often can have devastating consequences.
22 hours ago